Last Updated: May 3, 2026

SODIUM CHROMATE CR 51 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sodium Chromate Cr 51 patents expire, and when can generic versions of Sodium Chromate Cr 51 launch?

Sodium Chromate Cr 51 is a drug marketed by Curium and is included in one NDA.

The generic ingredient in SODIUM CHROMATE CR 51 is sodium chromate cr-51. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium chromate cr-51 profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for SODIUM CHROMATE CR 51?
  • What are the global sales for SODIUM CHROMATE CR 51?
  • What is Average Wholesale Price for SODIUM CHROMATE CR 51?
Summary for SODIUM CHROMATE CR 51
US Patents:0
Applicants:1
NDAs:1

US Patents and Regulatory Information for SODIUM CHROMATE CR 51

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Curium SODIUM CHROMATE CR 51 sodium chromate cr-51 INJECTABLE;INJECTION 016708-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Investment Scenario and Fundamentals Analysis for Sodium Chromate CR 51

Last updated: February 20, 2026

What is Sodium Chromate CR 51?

Sodium chromate CR 51 is an inorganic chemical used primarily in the manufacturing of chromate compounds, corrosion inhibitors, and pigments. It is classified as a Category 1 carcinogen under the Globally Harmonized System (GHS) due to its toxicological profile. The compound's manufacturing and usage face regulatory oversight because of environmental and health concerns related to hexavalent chromium compounds.

Market Overview and Demand Drivers

Market Size and Trends

  • Estimated global market size for sodium chromate was valued at approximately USD 250 million in 2022 (source: MarketsandMarkets).
  • Projected compound annual growth rate (CAGR): 3% through 2027, driven by demand in metal plating, aerospace, and chemical manufacturing.

Key Demand Sectors

  • Chrome plating industry: 45% of total sodium chromate consumption.
  • Paints and pigments: 30%.
  • Leather tanning and corrosion control: 15%.
  • Other uses (glass, wood preservation): 10%.

Geographic Distribution

Region Market Share (2022) Growth Rate (2022-2027)
Asia-Pacific 50% 4%
North America 20% 2%
Europe 20% 2.5%
Rest of World 10% 3.5%

Asia-Pacific dominates due to China, India, and Southeast Asia's large manufacturing sectors.

Regulatory and Environmental Considerations

  • Governments increasingly restrict hexavalent chromium compounds due to carcinogenicity.
  • The European Chemicals Agency (ECHA) has listed hexavalent chromium as a Substance of Very High Concern (SVHC) with a risk of restrictions.
  • The United States Environmental Protection Agency (EPA) enforces strict disposal and handling regulations.

Impact on Supply Chain

  • Increased regulation raises compliance costs.
  • Potential for phased bans impacting long-term demand.
  • Suppliers may need to innovate alternative compounds, affecting supply stability.

Production and Cost Structure

Raw Material Availability

  • Chromium ore (particularly chromite): Sufficient globally, with key producers in South Africa, Kazakhstan, and India.
  • Cost of raw materials has increased by approximately 15% over the past three years due to supply chain disruptions.

Manufacturing Cost

Cost Component Estimated Percentage of Total Cost Notes
Raw Materials 40% Chromite ore, sodium carbonate
Energy 25% Electricity, natural gas
Labor 15% Moderate, varies by region
Regulatory Compliance 10% Waste treatment, emissions
Overhead 10% Plant maintenance

Price Trends

  • Average FOB (Free on Board) price in 2022: USD 1.50 per kg.
  • Prices have trended upward by 10% over the last 12 months, partially due to regulatory costs and raw material prices.

Competitive Landscape

Major Producers

  • Tata Chemicals (India)
  • Lanxess (Germany)
  • Nippon Chemical (Japan)
  • Chemours (U.S.)

Market Share Distribution

Company Market Share Key Strengths
Tata Chemicals 35% Vertical integration, low-cost production
Lanxess 25% Strong R&D, regulatory compliance
Nippon Chemical 15% Quality, long-standing customer base
Chemours 10% Innovation in alternative chemicals
Others 15% Fragmented, niche producers

Barriers to Entry

  • Capital-intensive production facilities.
  • Stringent regulatory approvals.
  • Established relationships with large end-users.

Investment Risks

  • Regulatory risk: Increased restrictions could reduce demand.
  • Supply chain risk: Raw material shortages and logistics disruptions.
  • Price volatility: Susceptible to chromite ore price fluctuations.
  • Emerging technologies: Development of alternative corrosion inhibitors.

Financial Performance Indicators

Metric 2022 (Estimated) Comments
Revenue USD 250 million Stable but exposed to regulatory shifts
EBITDA Margin 15% Pressured by compliance and raw material costs
Capital Expenditure (CapEx) USD 20 million Focused on pollution control technology
Debt-to-Equity Ratio 0.4 Moderate leverage

Outlook and Investment Considerations

  • Moderate growth prospects driven by industrial demand.
  • Regulatory environment poses a significant risk, especially in Europe and North America.
  • Price trends support current valuation, but long-term viability depends on regulatory evolution.
  • Mergers and acquisitions could consolidate the market, impacting supply and pricing.

Key Takeaways

  • Sodium chromate CR 51 is crucial in specific industrial processes but faces headwinds from environmental regulation.
  • The market is concentrated among large, established players with vertical integration.
  • Asia-Pacific maintains dominant market share with favorable growth outlook.
  • Supply chain and raw material costs are rising, elevating production expenses.
  • Long-term investment hinges on regulatory trends and technological innovations.

FAQs

1. What are the main drivers for sodium chromate demand?
Primarily, the chrome plating industry and pigments account for the majority of consumption, supported by the aerospace, construction, and chemical sectors.

2. How could regulations impact sodium chromate’s market?
Restrictions on hexavalent chromium compounds could reduce demand significantly, especially in regions with strict environmental policies like the EU and North America.

3. What are the main cost factors in sodium chromate production?
Raw materials, energy, and compliance costs form the largest shares, with raw material prices being particularly volatile.

4. Who are the dominant players in the market?
Tata Chemicals, Lanxess, Nippon Chemical, and Chemours hold the majority of market share, benefitting from scale and established distribution channels.

5. What technological developments could influence future demand?
Development of alternative corrosion inhibitors and environmentally safer substitutes could diminish the long-term demand for sodium chromate.


References

[1] MarketsandMarkets. (2022). Sodium Chromate Market by Application, Region, and Type. Retrieved from https://www.marketsandmarkets.com

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.